SV2002000442A - Metodo para regular la angiogenesis usando proteina ryk ref. msb-7266-sv - Google Patents
Metodo para regular la angiogenesis usando proteina ryk ref. msb-7266-svInfo
- Publication number
- SV2002000442A SV2002000442A SV2001000442A SV2001000442A SV2002000442A SV 2002000442 A SV2002000442 A SV 2002000442A SV 2001000442 A SV2001000442 A SV 2001000442A SV 2001000442 A SV2001000442 A SV 2001000442A SV 2002000442 A SV2002000442 A SV 2002000442A
- Authority
- SV
- El Salvador
- Prior art keywords
- ryk
- msb
- regulating angiogenesis
- association
- protein ref
- Prior art date
Links
- 230000033115 angiogenesis Effects 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000028571 Occupational disease Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000002780 macular degeneration Diseases 0.000 abstract 1
- 230000006884 regulation of angiogenesis Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56878300A | 2000-05-10 | 2000-05-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SV2002000442A true SV2002000442A (es) | 2002-07-03 |
Family
ID=24272718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SV2001000442A SV2002000442A (es) | 2000-05-10 | 2001-05-09 | Metodo para regular la angiogenesis usando proteina ryk ref. msb-7266-sv |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1287121A2 (https=) |
| JP (1) | JP2004527206A (https=) |
| AR (1) | AR028424A1 (https=) |
| AU (1) | AU2001261343A1 (https=) |
| CA (1) | CA2408349A1 (https=) |
| CO (1) | CO5300464A1 (https=) |
| DO (1) | DOP2001000164A (https=) |
| EC (1) | ECSP014068A (https=) |
| GT (1) | GT200100079A (https=) |
| PE (1) | PE20011218A1 (https=) |
| SV (1) | SV2002000442A (https=) |
| UY (1) | UY26696A1 (https=) |
| WO (1) | WO2001085789A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1471934A2 (en) * | 2002-02-06 | 2004-11-03 | DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung | Kinases involved in the regulation of energy homeostasis |
| JO3283B1 (ar) | 2011-04-26 | 2018-09-16 | Sanofi Sa | تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI) |
| KR102486321B1 (ko) | 2014-07-18 | 2023-01-09 | 사노피 | 암을 앓고 있는 것으로 의심되는 환자를 아플리베르셉트로 치료한 결과를 예측하는 방법 |
| CA3229528A1 (en) * | 2021-08-18 | 2023-02-23 | The Regents Of The University Of California | Anti-related-to-receptor tyrosine kinase (ryk) antibodies and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07506969A (ja) * | 1992-05-11 | 1995-08-03 | ルードヴィッヒ・インスティテュート・フォア・キャンサー・リサーチ | レセプタ型チロシンキナーゼ類似の分子 |
| NZ328371A (en) * | 1994-12-23 | 1999-05-28 | Ludwig Inst Cancer Res | Method of detecting a ligand capable of binding the receptor protein neuroepithelial tyrosine kinase (nyk) and its use in therapeutic compositions |
| AU4278299A (en) * | 1998-06-11 | 1999-12-30 | Astrazeneca Ab | Human receptor tyrosine kinase |
| CA2348835A1 (en) * | 1998-10-28 | 2000-05-04 | Cornell Research Foundation, Inc. | Methods for regulating angiogenesis and vascular integrity using trk receptor ligands |
-
2001
- 2001-05-07 GT GT200100079A patent/GT200100079A/es unknown
- 2001-05-07 AR ARP010102149A patent/AR028424A1/es not_active Application Discontinuation
- 2001-05-08 UY UY26696A patent/UY26696A1/es not_active Application Discontinuation
- 2001-05-09 AU AU2001261343A patent/AU2001261343A1/en not_active Abandoned
- 2001-05-09 CA CA002408349A patent/CA2408349A1/en not_active Abandoned
- 2001-05-09 WO PCT/US2001/015043 patent/WO2001085789A2/en not_active Ceased
- 2001-05-09 SV SV2001000442A patent/SV2002000442A/es not_active Application Discontinuation
- 2001-05-09 JP JP2001582388A patent/JP2004527206A/ja active Pending
- 2001-05-09 EC EC2001004068A patent/ECSP014068A/es unknown
- 2001-05-09 CO CO01036462A patent/CO5300464A1/es unknown
- 2001-05-09 EP EP01935233A patent/EP1287121A2/en not_active Withdrawn
- 2001-05-10 DO DO2001000164A patent/DOP2001000164A/es unknown
- 2001-05-10 PE PE2001000417A patent/PE20011218A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DOP2001000164A (es) | 2002-05-15 |
| EP1287121A2 (en) | 2003-03-05 |
| GT200100079A (es) | 2001-12-31 |
| CA2408349A1 (en) | 2001-11-15 |
| UY26696A1 (es) | 2001-12-28 |
| ECSP014068A (es) | 2002-02-25 |
| CO5300464A1 (es) | 2003-07-31 |
| JP2004527206A (ja) | 2004-09-09 |
| AU2001261343A1 (en) | 2001-11-20 |
| AR028424A1 (es) | 2003-05-07 |
| WO2001085789A3 (en) | 2002-05-16 |
| WO2001085789A2 (en) | 2001-11-15 |
| PE20011218A1 (es) | 2002-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE340581T1 (de) | Verfahren zur behandlung von prostaterkrankungen unter verwendung von vitamin-d-formulierungen mit verzögerter und/oder verlängerter wirkstofffreigabe | |
| SV1995000007A (es) | Derivados del acido micofenolico 5-substituidos. | |
| ES2166783T3 (es) | Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii. | |
| CY1107248T1 (el) | Συντηγμενες πρωτεϊνες | |
| NO962088D0 (no) | Preparat for in vivo-produksjon av terapeutiske produkter | |
| ECSP045065A (es) | Queratinocitos utilizables como sustancia biológicamente activa en el tratamiento de heridas | |
| IS4083A (is) | Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja | |
| ATE466592T1 (de) | Anwendung von glp-2 in verbindung mit einem anderen therapeutischen mittel in knochenkrankheiten | |
| ATE290401T1 (de) | Topisch anwendbare mittel gegen nagelpilzerkrankungen | |
| ES2194935T3 (es) | Preparados estables de transglutaminasa y procedimiento para su preparacion. | |
| BR0204596A (pt) | Composição tópica, e, métodos para melhorar a aparência estética da pele, para intensificar a eficácia terapêutica de uma composição tópica para a pele, unha, lábios e/ou cabelo e para intensificar a produção de um constituinte de célula de planta predeterminada | |
| ATE365550T1 (de) | Verwendung von einem protein kinase hemmer wie z.b. genistein bei der behandlung von diabetischer retinopathie | |
| MXPA02012075A (es) | Composicion para mediar el dolor y aparato y metodo para utilizarla. | |
| ES2077559T3 (es) | Estabilizacion de proteinas terapeuticamente activas en preparados farmaceuticos. | |
| SV2002000442A (es) | Metodo para regular la angiogenesis usando proteina ryk ref. msb-7266-sv | |
| DK1343472T3 (da) | Thixotropisk næsespray | |
| MX9701996A (es) | Utlizacion de 3-oxo de 2, 4-diamino-pirimidina o una de sus sales en el tratamiento de desordenes dela maduracion y de la estructuracion del colageno. | |
| ES2110057T3 (es) | Composicion medicinal que contiene tcf-ii. | |
| ATE283058T1 (de) | Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von dysphorie | |
| CY1107346T1 (el) | Φαρμακευτικη συνθεση για την ενδοκυτταρια οξινιση με cis-ουροκανικο οξυ | |
| SV2002000362A (es) | Proteinas que tienen una actividad moduladora de angiogenesis ref.msb-7265-sv | |
| CO5070621A1 (es) | Metodo para incrementar el volumen oseo | |
| AR024497A1 (es) | Composiciones cosmeticas para el cuidado de la piel que contienen alcohol cumico | |
| ITTO20000441A0 (it) | Composizione terapeutica per la cura della psoriasi. | |
| DOP2001000141A (es) | Proteina actuando como un modulador angiogenico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Lapse |